Robert Incoom

The researcher has conducted extensive work across a broad range of topics within pharmacology and public health. Their research primarily centers on the development and evaluation of strategies for improving antibiotic utilization in developing countries, addressing global challenges such as antimicrobial resistance and reducing antibiotic overuse. The researcher has examined the role of pharmaceuticals and pharmacoeconomics in mitigating these challenges, particularly focusing on the availability and economic impacts of biosimilars across African, Asian, European, and South American nations. Their work also highlights the importance of patient outcomes through studies of antibiotics sold without prescriptions and their impact on community pharmacies and drug outlets. Additionally, the researcher has explored the pharmacoeconomic implications of antibiotic stewardship practices, including long-acting insulin analogues and their biosimilars. Through these investigations, the researcher has provided valuable insights into the sustainable use of pharmaceuticals for public health purposes.